Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA

BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Tamoxifen lowered breast cancer rates among high-risk women ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Impact of adding bevacizumab to presurgery chemo for triple-negative breast...

Dr William Sikov - Women and Infants Hospital, Providence, USA

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )

Fulvestrant improves survival over anastrozole for patients with advanced...

Prof John Robertson - Royal Derby Hospital, Derby, UK

Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )

Progression-free survival results from BOLERO-1 trial

Prof Sara Hurvitz - University of California, Los Angeles, USA

Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )

Lowering dietary fat intake reduces death rates in some women with breast cancer

Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA

Lowering dietary fat intake reduces death rates in some women with breast cancer ( Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )

Multigene test can predict risk of disease recurrence for women with ductal...

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal...

Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )

Comment: Capecitabine for elderly early-stage breast cancer

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Capecitabine for elderly early-stage breast cancer ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Capecitabine monotherapy does not improve survival in elderly patients with...

Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany )

Impact of adding bevacizumab to presurgery chemo for triple-negative breast...

Dr William Sikov - Women and Infants Hospital, Providence, USA

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )

More from ecancer